Debt-to-equity in % of Aura Biosciences, Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aura Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2025.
  • Aura Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2025 was 19.8 %, a 40.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

Aura Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 19.8 +5.7 +40.4% Sep 30, 2025
Q2 2025 18.8 +4.63 +32.6% Jun 30, 2025
Q1 2025 17.9 +3.28 +22.5% Mar 31, 2025
Q4 2024 15.7 +0.62 +4.11% Dec 31, 2024
Q3 2024 14.1 -1.52 -9.73% Sep 30, 2024
Q2 2024 14.2 -2.32 -14.1% Jun 30, 2024
Q1 2024 14.6 +0.37 +2.6% Mar 31, 2024
Q4 2023 15.1 +3.44 +29.5% Dec 31, 2023
Q3 2023 15.6 +6.87 +78.5% Sep 30, 2023
Q2 2023 16.5 +7.79 +89.4% Jun 30, 2023
Q1 2023 14.2 Mar 31, 2023
Q4 2022 11.7 Dec 31, 2022
Q3 2022 8.76 Sep 30, 2022
Q2 2022 8.71 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.